Genetic Technologies Narrows Half-Year Loss Despite Zero RevenueTip Ranks·Sep 14, 2026 at 05:57 AMGENE
Genetic Technologies to Wind Down U.S. ADR Program Amid ASX Trading SuspensionTip Ranks·Jun 22, 2026 at 12:42 AMGENE
enGene Therapeutics Rebrands as Company Nears CommercializationTip Ranks·Apr 9, 2026 at 08:38 PMENGNW+78.85%ARKG-4.24%
Availability of Transgene's 2025 Universal Registration Document (URD)Unusual Whales·Apr 9, 2026 at 04:05 PM2342GENE
Your Genetic Wellness Partners with Senior Care Expert Lance A. Slatton to Expand Reach of Actionable BiologyMorningStar·Apr 3, 2026 at 09:10 PMGENE
Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA ContinuesTip Ranks·Mar 30, 2026 at 01:52 AMGENE
Genetic Technologies Advances Restructuring as Cash Reserves DwindleTip Ranks·Mar 30, 2026 at 01:52 AMGENE
Genetic Technologies Director Musgrave Steps Down With No ShareholdingTip Ranks·Mar 27, 2026 at 01:12 AMGENE
Genetic Technologies Discloses Board Exit of Director Steven NicolsTip Ranks·Mar 27, 2026 at 01:12 AMGENE
Genetic Technologies Reshapes Board With New Director Appointments and ResignationsTip Ranks·Mar 24, 2026 at 07:03 AMGENE
Genetic Technologies Drops Wealth Firm Deal to Refocus on Relisting StrategyTip Ranks·Mar 24, 2026 at 01:42 AMGENE
Genedrive shareholders back fundraising as company expands pharmacogenetic footprintTip Ranks·Mar 9, 2026 at 11:33 AMGNCAQ0.00%GENE
21:00 ETGene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026prnewswire·Mar 4, 2026 at 02:00 AMGENEPBE-1.84%
Helix partners with Mawi DNA Technologies to expand genomic sample collection with buccal swab tech, increasing participation.Unusual Whales·Feb 10, 2026 at 02:07 PMPBE-1.84%APDN0.00%
